Baxter
BAX
#1140
Rank
NZ$27.81 B
Marketcap
$54.48
Share price
0.82%
Change (1 day)
-8.33%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$22.74 Billion

According to Baxter's latest financial reports the company's total debt is NZ$22.74 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Baxter - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$22.71 B-16.17%
2022-12-31NZ$27.09 B1.08%
2021-12-31NZ$26.80 B184.27%
2020-12-31NZ$9.42 B6.54%
2019-12-31NZ$8.85 B70.36%
2018-12-31NZ$5.19 B5.06%
2017-12-31NZ$4.94 B23.13%
2016-12-31NZ$4.01 B-57.76%
2015-12-31NZ$9.50 B-17.5%
2014-12-31NZ$11.52 B3.31%
2013-12-31NZ$11.15 B54.74%
2012-12-31NZ$7.20 B8.3%
2011-12-31NZ$6.65 B17.06%
2010-12-31NZ$5.68 B-0.5%
2009-12-31NZ$5.71 B-11.7%
2008-12-31NZ$6.47 B60.5%
2007-12-31NZ$4.03 B1.43%
2006-12-31NZ$3.97 B-18.59%
2005-12-31NZ$4.88 B-18.85%
2004-12-31NZ$6.01 B-14.48%
2003-12-31NZ$7.03 B-20.76%
2002-12-31NZ$8.87 B37.22%
2001-12-31NZ$6.47 B21.51%
2000-12-31NZ$5.32 B-2.55%
1999-12-31NZ$5.46 B-14.46%
1998-12-31NZ$6.38 B33.41%
1997-12-31NZ$4.78 B65.77%
1996-12-31NZ$2.88 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$8.80 B-61.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.39 B 16.05%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.18 B-15.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.93 B 44.82%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.56 B-88.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$60.19 B 164.66%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.70 B-83.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$47.49 B 108.84%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$2.86 B-87.42%๐Ÿ‡บ๐Ÿ‡ธ USA